Compare Neurocrine Biosciences Inc (NBIX) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Taskus Inc — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: Neurocrine Biosciences Inc is far larger — about 32.7× Taskus Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | TASK | |
|---|---|---|
Market Cap | $17.40B | $532.07M |
Sector | Health | Technology |
52-Week High | $180.55 | $18.21 |
52-Week Low | $123.10 | $4.57 |
Enterprise Value | $16.49B | $927.77M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
